How have OABIW shares performed in 2024?

OmniAb's stock was trading at $1.03 at the beginning of 2024. Since then, OABIW shares have decreased by 46.6% and is now trading at $0.55. View the best growth stocks for 2024 here .

How do I buy shares of OmniAb?

Shares of OABIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:OABIW

OmniAb (OABIW) Stock Price, News & Analysis

→ Move Your Money Before May 1 (From Stansberry Research) (Ad)

Free OABIW Stock Alerts

$0.55

0.00 (0.00%)

(As of 05:27 PM ET)

Compare

Today's Range: $0.50
▼
$0.56
50-Day Range: $0.50
▼
$1.25
52-Week Range: $0.40
▼
$1.50

Volume: 23,100 shs
Average Volume: 10,772 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Social Media

Get OmniAb alerts:

Ad Weiss Ratings

The Next Step of Their Control Is Here …

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

About OmniAb

OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California.

OABIW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OABIW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive OABIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:OABIW
CUSIP: N/A
CIK: 1846253
Web: www.omniab.com
Phone: 510 250 7800
Fax: N/A
Employees: 106
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $34.16 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Matthew W. Foehr (Age 51)
President, CEO & Director
Comp: $967.72k
Mr. Kurt A. Gustafson (Age 56)
Executive VP of Finance & CFO
Comp: $558.48k
Mr. Charles S. Berkman J.D. (Age 55)
Chief Legal Officer & Secretary
Comp: $734.33k
Ms. Cia McCaffrey
Vice President of People & Talent
Dr. Bill Harriman Ph.D.
Senior Vice President of Antibody Discovery
Ms. Marie-Cecile van de Lavoir D.V.M.
Ph.D., Senior Vice President of Technical Operations & Genetics
Dr. Christel Iffland Ph.D.
Senior Vice President of Antibody Technologies
Dr. Douglas S. Krafte Ph.D. (Age 66)
Senior VP of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
Ms. Donna Ventura CPA
Senior Vice President of Corporate Controller

Key Competitors

View All Competitors

OABIW Stock Analysis - Frequently Asked Questions

How have OABIW shares performed in 2024?: OmniAb's stock was trading at $1.03 at the beginning of 2024. Since then, OABIW shares have decreased by 46.6% and is now trading at $0.55.
View the best growth stocks for 2024 here.
How do I buy shares of OmniAb?: Shares of OABIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OABIW) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial